Skip to main content

Table 2 Life table for OS, DP, LC

From: Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)

  Proportion surviving after
1-year 2-year 3-year 4-year 5-year 10-year
OS 74% 54% 39% 29% 26% 17%
DP 58% 46% 40% 37% 34% 32%
LC 92% 84% 78% 77% 75% 75%
  1. OS Overall survival, DP Distant progression, LC Local control